Parcion Private Wealth’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.5K | Buy |
30,785
+392
| +1% | +$439 | ﹤0.01% | 297 |
|
|
2025
Q1 | $24K | Buy |
30,393
+2,393
| +9% | +$1.89K | ﹤0.01% | 286 |
|
|
2024
Q4 | $46.2K | Hold |
28,000
| – | – | ﹤0.01% | 239 |
|
|
2024
Q3 | $98K | Hold |
28,000
| – | – | 0.01% | 235 |
|
|
2024
Q2 | $91.8K | Hold |
28,000
| – | – | 0.01% | 194 |
|
|
2024
Q1 | $206K | Hold |
28,000
| – | – | 0.02% | 188 |
|
|
2023
Q4 | $105K | Hold |
28,000
| – | – | 0.01% | 187 |
|
|
2023
Q3 | $59.4K | Hold |
28,000
| – | – | 0.01% | 182 |
|
|
2023
Q2 | $133K | Hold |
28,000
| – | – | 0.01% | 179 |
|
|
2023
Q1 | $160K | Hold |
28,000
| – | – | 0.02% | 181 |
|
|
2022
Q4 | $283K | Hold |
28,000
| – | – | 0.03% | 167 |
|
|
2022
Q3 | $627K | Hold |
28,000
| – | – | 0.07% | 132 |
|
|
2022
Q2 | $869K | Hold |
28,000
| – | – | 0.09% | 130 |
|
|
2022
Q1 | $1.09M | Hold |
28,000
| – | – | 0.1% | 106 |
|
|
2021
Q4 | $1.21M | Hold |
28,000
| – | – | 0.11% | 101 |
|
|
2021
Q3 | $1.72M | Hold |
28,000
| – | – | 0.15% | 98 |
|
|
2021
Q2 | $2.43M | Hold |
28,000
| – | – | 0.24% | 86 |
|
|
2021
Q1 | $2.31M | Hold |
28,000
| – | – | 0.26% | 86 |
|
|
2020
Q4 | $2.55M | Hold |
28,000
| – | – | 0.34% | 63 |
|
|
2020
Q3 | $1.07M | Hold |
28,000
| – | – | 0.16% | 93 |
|
|
2020
Q2 | $1.03M | Hold |
28,000
| – | – | 0.17% | 87 |
|
|
2020
Q1 | $622K | Buy |
+28,000
| New | +$622K | 0.17% | 87 |
|